Systemic effects of mydriatics in low weight infants

Area of Science:

• Ophthalmology
• Pediatric Medicine
• Pharmacology

Background:

• Routine pupillary dilation is essential for ophthalmic examinations in infants.
• Low-weight infants represent a high-risk population for potential adverse drug reactions.
• Phenylephrine, a sympathomimetic agent, is commonly used for pupillary dilation.

Purpose of the Study:

• To evaluate the safety and efficacy of combining phenylephrine eye drops with tropicamide for pupillary dilation in low-weight infants.
• To assess the impact of this combination on systolic blood pressure and pupillary dilation compared to cycloplegics alone.

Main Methods:

• A study group of 10 low-weight infants received phenylephrine 2.5% eye drops combined with tropicamide 0.5%.
• A matched control group received cycloplegic agents (tropicamide) alone for pupillary dilation.
• Systolic blood pressure and pupillary dilation were measured and compared between groups.

Main Results:

• Eight out of 10 infants in the study group experienced significant systolic blood pressure elevation.
• The control group, dilated with cycloplegics alone, did not show a significant rise in systolic blood pressure.
• While pupillary dilation was slightly greater in the study group (3.9 mm vs. 3.1 mm), the difference was not statistically significant.

Conclusions:

• The combination of phenylephrine and tropicamide eye drops is associated with significant systolic blood pressure elevation in low-weight infants.
• Cycloplegic agents alone appear to be a safer alternative for pupillary dilation in this high-risk infant population.
• It is recommended to use cycloplegic agents solely for routine pupillary dilation in low-weight, high-risk infants.